After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...
A lawsuit against UnitedHealth Group over its wrongful denials of post-acute care under Medicare Advantage plans, including nursing home services, ...
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
Humana shares were rising early Tuesday after the health insurer said it expects its earnings this year to be broadly flat.
While the case will proceed, the federal court agreed in part with a UnitedHealth Group motion and dismissed some claims.
Rising health insurance exhange enrollment, paired with stricter Medicare marketing rules, attracted rogue actors to the ...
The company saw big bills related to cancer, premature births and hospital prices driving up claim severity in the fourth ...
For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.
2d
Zacks.com on MSNShould You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results